4 Tips For Advancing Your AAV Manufacturing Plans

By Tim Kelly

Manufacturing is no simple task for adeno-associated virus (AAV)-based gene therapy and gene editing product development. As the industry advances these genetic medicines, manufacturing is also ramping up, and with it, optimization and efficiencies of scale. Since the industry is still maturing, and manufacturing know-how is often kept proprietary, companies must learn, adapt, and master novel innovations as well as challenges on their own.